Engineered virus injected into tumors to fight advanced colon cancer
NCT ID NCT05733611
Summary
This study tested a new combination treatment for advanced colorectal cancer that has stopped responding to standard therapies. It involved directly injecting a genetically engineered virus into tumors to kill cancer cells and boost the immune system, while also giving two other drugs that help block cancer's blood supply and immune evasion. The trial was for patients whose cancer had spread and was no longer controlled by common chemotherapy drugs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY METASTATIC COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
USC Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
-
University of Washington Seattle Cancer Care Alliance
Seattle, Washington, 98109, United States
Conditions
Explore the condition pages connected to this study.